These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2805631)

  • 21. Netilmicin therapy of serious renal and urinary tract infections in patients with normal and impaired renal function.
    Denneberg T; Haeger K; Juhlin I
    Scand J Infect Dis Suppl; 1980; Suppl 23():135-40. PubMed ID: 6937958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gentamicin and tobramycin in patients with various infections--concentrations in serum and urinary excretion.
    Kahlmeter G; Hallberg T; Kamme C
    J Antimicrob Chemother; 1978 May; 4 Suppl A():37-45. PubMed ID: 659348
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparative study of gentamicin and netilmicin in the treatment of gram-negative infections.
    LeFrock JL; Carr BB; Blias F; Schell RF; Dematteo C; Tillotson JR
    Drug Intell Clin Pharm; 1985 Apr; 19(4):309-15. PubMed ID: 3891278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Netilmicin in the treatment of gram-negative bacillary infections.
    Messihi J; Smith LG; Najjar S
    J Med Soc N J; 1983 Mar; 80(3):193-6. PubMed ID: 6575181
    [No Abstract]   [Full Text] [Related]  

  • 25. Netilmicin in gram-negative bacterial infections.
    Snydman DR; Tally FP; Landesman SH; Barza M; Gorbach SL
    Antimicrob Agents Chemother; 1979 Jan; 15(1):50-4. PubMed ID: 426506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis.
    Mann HJ; Fuhs DW; Awang R; Ndemo FA; Cerra FB
    Clin Pharm; 1987 Feb; 6(2):148-53. PubMed ID: 3665367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Netilmicin treatment of complicated urinary tract infections.
    Madsen PO; Baumueller A; Frimodt-Møller N; Hoyme U; Lau C; Maigaard S; Nielsen OS; Welling PG
    Scand J Infect Dis Suppl; 1980; Suppl 23():128-31. PubMed ID: 6937956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting aminoglycoside dosage in critically ill patients with sepsis.
    Stevens MR
    Clin Pharm; 1987 Apr; 6(4):272-3. PubMed ID: 3665382
    [No Abstract]   [Full Text] [Related]  

  • 29. Renal toxicity during therapy with gentamicin or tobramycin.
    Keys TF; Kurtz SB; Jones JD; Muller SM
    Mayo Clin Proc; 1981 Sep; 56(9):556-9. PubMed ID: 6115104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Netilmicin: clinical evaluation of efficacy and toxicity of a new aminoglycoside.
    Nordström L; Christensson P; Haeger K; Juhlin I; Tjernström O; Wallmark E
    J Int Med Res; 1979; 7(2):117-26. PubMed ID: 478159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and microbiologic consequences of amikacin use during a 42-month period.
    Berk SL; Alvarez S; Ortega G; Verghese A; Holtsclaw-Berk SA
    Arch Intern Med; 1986 Mar; 146(3):538-41. PubMed ID: 3954526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity of gentamicin-resistant gram-negative bacilli to tobramycin, netilmicin and amikacin as well as synergism with cephalosporins.
    Kedzia WB; Mirska I
    J Chemother; 1989 Jul; 1(4 Suppl):367-8. PubMed ID: 16312443
    [No Abstract]   [Full Text] [Related]  

  • 33. Netilmicin therapy of gentamicin-sensitive and resistant gram-negative infections.
    Pollock AA; Stein AJ; Simberkoff MS; Rahal JJ
    Am J Med Sci; 1981; 282(1):2-11. PubMed ID: 6973928
    [No Abstract]   [Full Text] [Related]  

  • 34. Netilmicin versus tobramycin in multi-centre studies.
    Daschner FD; Just HM; Jansen W; Lorber R
    J Antimicrob Chemother; 1984 Jan; 13 Suppl A():37-45. PubMed ID: 6365881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and bactericidal activity of a single daily dose of netilmicin in the treatment of CAPD-associated peritonitis.
    Anding K; Krumme B; Pelz K; Böhler J; Schollmeyer P
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):465-9. PubMed ID: 8937927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of resistance to netilmicin and other aminoglycosides.
    Toscano MA; Russo G; Nicoletti G; Stefani S; Geraci C; Alessandria E
    Chemioterapia; 1986 Jun; 5(3):191-5. PubMed ID: 3719853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of gentamicin resistance in gram-negative bacteria in Czechoslovakia and correlation with its usage.
    Kettner M; Krćméry V
    Drugs Exp Clin Res; 1988; 14(8):511-7. PubMed ID: 2854783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Once-daily gentamicin versus once-daily netilmicin in patients with serious infections--a randomized clinical trial.
    Prins JM; Büller HR; Kuijper EJ; Tange RA; Speelman P
    J Antimicrob Chemother; 1994 Apr; 33(4):823-35. PubMed ID: 8056701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Netilmicin in the treatment of respiratory infections].
    Marsico SA; Sanduzzi A; Del Donno M; Vatrella A
    Arch Monaldi; 1984; 39(1-2):53-60. PubMed ID: 6442557
    [No Abstract]   [Full Text] [Related]  

  • 40. Netilmicin treatment of serious infections in patients with renal insufficiency.
    Jonsson M; Julander I; Tunevall G; Haeger K
    J Int Med Res; 1978; 6(3):226-34. PubMed ID: 648740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.